glp 1 crohn's disease GLP-1 for Disease: Current Evidence and Treatment Options Frontiers | GLP-1 receptor agonists

Compared with active drugs, oral semaglutide was superior to empagliflozin in reducing total cholesterol and LDL [36] and was superior to sitagliptin in reducing total cholesterol, LDL, and TAGs [37, 41], but there was no significant difference when compared with another GLP-1 analogue (liraglutide) [38]

The synergistic relationship between GLP-1 and GIP appears to enhance satiety and energy balance more effectively than either hormone alone, as evidenced by the superior results of tirzepatide over semaglutide in the SURMOUNT-5 head-to-head trials

I am no experiencing any energy dips or muscle mass loss

Conformment mes indications, jai demand cette patient de faire un rgime aprs lintervention (surtout pas avant)